About this Event
Discover the findings from a recent five-year study on light therapy for Parkinson’s disease in this exclusive webinar. Dr Mike Hobbs (Chiro), SYMBYX’s Research and Clinical Services Manager, will present the latest research, including results from the 5 year follow up study published in BMC Neurology, 2024, demonstrating how light therapy is changing the landscape of Parkinson’s treatment.
In this session, we will delve into the mechanisms of light therapy and explore its role in managing Parkinson’s symptoms.
Webinar Highlights:
• An overview of how light therapy works to alleviate Parkinson’s symptoms.
• Exclusive insights from the five-year research results, showing sustained improvements in motor function, and cognition
• How light therapy can be applied in clinical practice, based on real-world patient outcomes and cutting-edge science.
This webinar will provide healthcare professionals, researchers, and clinicians with practical, evidence-based insights into incorporating light therapy into Parkinson’s care. The five-year results underscore the long-term benefits and feasability of this non-invasive treatment, for Parkinson’s symptom management.
Why attend?
Be among the first to hear about the results that are changing how we approach Parkinson’s treatment. Whether you’re looking to expand your therapeutic options or stay informed about the latest advances, this webinar will provide you with the data and tools you need.
*This webinar is exclusively for qualified health and fitness professionals. Proof of your professional registration number in your country is required to be able to attend.
Date: 4 December 2024
Time: 4 Dec, 3:30pm (NYC), 8:30pm (UK) | 5 Dec, 7:30am (Sydney)
Reserve your spot today and be part of the future of Parkinson’s care.
Event Venue
Online
AUD 0.00